Institutional Ownership
Apellis Pharmaceuticals Inc
CUSIP 03753UAB2NOTE 3.500% 9/1APLS.3.5.09/15/26Q1 2026
Earnings
Quarterly EPS and revenue are sourced from SEC XBRL financial statements. We ingest the top issuers first; this fills in as coverage expands (or this security isn't mapped to an SEC filer yet).